
Breast Medical Oncologist from @IEOufficiale • Researcher @DFCI_BreastOnc • #FirstGen • Love hiking, rock music & kind people
Boston, MA
Joined April 2011
- Tweets5.9K
- Following899
- Followers2.5K
- Likes32.5K
Pinned Tweet
“We need #women who are so strong they can be #gentle, so #educated they can be #humble, so fierce they can be #compassionate, so #passionate they can be #rational, and so disciplined they can be #free.”
― Kavita N. Ramdas
Congrats @AdelaRodrguezH1 ! Such meaningful, important research that needs to be prioritized and funded!
✨Congratulations to BOC research fellow, Dr. Adela Rodriguez Hernandez, (@AdelaRodrguezH1) on receiving the Friends of Dana-Farber Award!
This award will support her research on whole genome sequencing to identify hidden inherited causes of #BreastCancer diagnosed at age 30 or younger.
Chiara Corti, MD retweeted
Replying to @AMJohnston1315
@AMJohnston1315 was a truly amazing individual-- she will be very missed.
Chiara Corti, MD retweeted
L'Italia è tra le migliori nazioni d'Europa nel garantire l'accesso ai farmaci anticancro innovativi. Altro che la narrazione dei brutti e cattivi che sta circolando da qualche tempo, complice il caso daraxonrasib... fondazioneveronesi.it/magazi… #ESMO26
When u come from a natural sciences background u know how fleeting existence is.
I found the deepest meaning of medicine & research in La Ginestra, by G.Leopardi, great Italian poet: recognizing our shared fragility should bind us in a “social chain” of solidarity & mutual care.
Pick any medical specialty other than your own. Who’s the most famous physician in it? You probably can’t name one.
Almost none of us will be known outside our field, and even those who achieve real professional fame are mostly forgotten within a few decades.
Fame is a poor reason to devote your life to medicine. The work itself matters more: caring for patients, discovering new knowledge, and teaching the next generation.
Curious to see how this "specialized" version rolls out. Medical AI for LMICs.
"Access to medical knowledge shouldn't depend on geography," said Daniel Nadler, founder and CEO of OpenEvidence.
That's why OpenEvidence and @AnthropicAI are bringing a specialized version of OpenEvidence, free, to clinicians in about 100 low- and middle-income countries, including Uganda, Angola, Sudan, Haiti, and Mongolia. More here: reuters.com/legal/litigation…
Chiara Corti, MD retweeted
Workers at The Lancet to stage first strike in title’s history researchprofessionalnews.com…
More than 1 billion pounds profit last year and they expect us to do peer review for free.
“Her life was a long struggle against everything that denies freedom: against clandestine abortion, world hunger, the stranglehold of party politics, female genital mutilation, punitive justice, genocide, and every form of authoritarianism”
Great to see this initiative by @myESMO amid rising costs/challenges of running trials. One of academia’s noblest missions is to answer KEY pragmatic questions (optimizing treatment, reducing tox,…), while industry & basic research investigate new strategies against cancer.
ESMO's new Clinical Trials Funding initiative supports independent academic pragmatic clinical trials to improve #CancerCare and patient outcomes. Open to academic institutions, hospitals, research groups.
Application deadline: 1 November 2026
ow.ly/482Q50ZLX3p
Chiara Corti, MD retweeted
Risk-Reducing Interventions in Women With Pathogenic Variants in Breast Cancer Susceptibility Genes | JCO Precision Oncology ascopubs.org/doi/10.1200/PO-…
When Doctors Become Influencers: Where Social Media Crosses the Professional Line
European medical bodies are now moving from providing broad professionalism principles toward more explicit guidance for physicians who communicate online.
As doctors take to social media, the line between education, advice, and promotion can blur. European guidance is spelling out where physicians should draw it.
mdsc.pe/4zt66h8
Chiara Corti, MD retweeted
An excellent piece in The Guardian. Seeing this and the article in @thetimes the other day, I’m at last daring to hope that real change might be on the way.
Well done @HysteroscopyA - you are stars 🌟 🌟🌟
Over to you @YvetteCooperMP
theguardian.com/society/2026…
A fantastic conclusion to the @sitcancer Women in Cancer Immunotherapy Network (WIN) #Leadership Institute.
Day 2 featured insightful discussions on building #intentionalteams, negotiation, setting boundaries, and allyship, led by an outstanding faculty from academia & industry.
Chiara Corti, MD retweeted
We are excited to kick-off our annual Women in Cancer Immunotherapy Network (WIN) Leadership Institute in Boston. Welcome to all of the ladies who were selected for this exclusive event. Keynote speaker is @JenniferGrandis, MD. Learn more about the WIN, sitcancer.org/career-develop…
Chiara Corti, MD retweeted
One of the best new things @DanaFarber is our Food Basket, open to all of our patients who face food insecurity or need a helping hand. Healthy groceries, available daily, free of charge, 1st Floor of Smith Bldg. Putting the 'comprehensive' in comprehensive cancer center.
Chiara Corti, MD retweeted
Replying to @OncBrothers @sdent_cardioonc @JCO_ASCO @dr_yakupergun @RenoHemonc @BijoyTelivala @realbowtiedoc @crisbergerot @SuyogCancer @RahulBanerjeeMD @stolaney1 @NVijayvergiaMD @PGrivasMDPhD
I offer low dose olanzapine (1.25-2.5mg) to patients basically on chemo. It works brilliantly. Breast cancer docs are really up on this because on Enhertu, but this needs to be adopted by all oncologists.
This is very interesting and complementary with the data we have about scanxiety after diagnosis.
#PatientCommunication
How should patients learn they have cancer?
Our new study in @JAMANetworkOpen of 2,400+ patients found that 75% prefer clinician delivery over a patient portal—highlighting the trade-off between immediate access to results and clinical guidance.
jamanetwork.com/journals/jam…
Chiara Corti, MD retweeted
First approval for iza-bren in China!
For the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma based on the results from the pivotal Phase III BL-B01D1-303!
prnewswire.com/news-releases…



























